Addressing Financial Toxicity Through Systematic Change.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 28
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 12
Results: 15
1
2
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 26
- By:
- Publication type:
- Article
3
Paradigm Shift: Radiation a New Standard in Prostate Cancer with Low Metastatic Burden.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 24
- By:
- Publication type:
- Article
4
Venclexta Approved in Combination for Older Adults with Acute Myeloid Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 23
- Publication type:
- Article
5
Adcetris First FDA-Approved Drug for CD30-Expressing Peripheral T-Cell Lymphomas.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 23
- Publication type:
- Article
6
Truxima First Biosimilar to Rituxan FDA-Approved for Non-Hodgkin Lymphoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 23
- Publication type:
- Article
7
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 20
- By:
- Publication type:
- Article
8
Xospata First Therapy Approved for Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 19
- Publication type:
- Article
9
Daurismo New Treatment Approved for Older Adults with Acute Myeloid Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 19
- Publication type:
- Article
10
Udenyca, Second Biosimilar to Neulasta, FDA-Approved to Reduce Risk for Infection in Patients with Nonmyeloid Malignancies.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 13
- Publication type:
- Article
11
Talzenna Approved for HER2-Negative, Locally Advanced Breast Cancer with Germline BRCA Mutations.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 13
- Publication type:
- Article
12
Harnessing the Power of Data Collection and Coordination in Oncology Practice.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 9
- By:
- Publication type:
- Article
13
Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 1
- By:
- Publication type:
- Article
14
First-Line Olaparib a New Standard in Women with Newly Diagnosed, BRCA-Positive Advanced Ovarian Cancer?
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 1
- By:
- Publication type:
- Article
15
MIPS: How to Be Successful Today and in the Future.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 12, p. 1
- By:
- Publication type:
- Article